Prioritizing Sarcopenia-Related Genes from Cross-Trait Candidate Regions: Regulatory Variant Mapping and Phenome-Wide Mendelian Randomization
International Journal of Molecular Sciences · 15.11.2026 · 27 (22) · 10258
DOI: 10.3390/ijms272210258 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.11.2026. Verfasst von Li Wang und 2 weiteren Autor:innen. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Department of Sichuan Province, National Natural Science Foundation of China, Shaanxi Provincial Department of Education.
Abstract (Originalsprache)
Sarcopenia involves declines in muscle mass, muscle strength, and physical function. Identifying effector genes, their favourable expression directions, and broader phenotypic associations from genome-wide association study (GWAS) signals remains challenging. We integrated GWAS summary statistics for hand grip strength (HGS) and appendicular lean mass (ALM) with H3K27ac annotation, AlphaGenome variant effect predictions, and skeletal muscle expression data. We then applied cis-eQTL Mendelian randomization (MR) and colocalization across HGS, ALM, low hand grip strength (LHGS), and usual walking pace. Across 59 HGS–ALM cross-trait candidate regions, AlphaGenome predicted 2288 regulatory variants among 16,245 candidate enhancer SNPs and nominated 135 protein-coding effector genes. Four-trait MR identified 30 genes with significant causal effects, including 13 with concordant effect directions across multiple traits. FGF6, CCND2, and HOXB3 also received strong colocalization support. Phenome-wide MR across 784 UK Biobank disease phenotypes revealed distinct benefit–risk profiles for 7 genes. Higher CCND2 expression improved sarcopenia-related traits and reduced type 2 diabetes risk but increased the risks of parathyroid disease and atrial fibrillation and flutter. Higher HOXB3 expression increased HGS and reduced the risks of LHGS and diverticular disease. Lower FGF6 expression increased ALM, with no risk-increasing effect detected. This workflow prioritizes skeletal muscle effector genes and their favourable expression directions for sarcopenia-related traits to guide functional validation and translation.
Förderung
- Science and Technology Department of Sichuan Province
- National Natural Science Foundation of China
- Shaanxi Provincial Department of Education
Zitieren
APA
Wang, L., Zhang, L., & Zhang, S. (2026). Prioritizing Sarcopenia-Related Genes from Cross-Trait Candidate Regions: Regulatory Variant Mapping and Phenome-Wide Mendelian Randomization. International Journal of Molecular Sciences, 27(22), 10258. https://doi.org/10.3390/ijms272210258
Vancouver
Wang L, Zhang L, Zhang S. Prioritizing Sarcopenia-Related Genes from Cross-Trait Candidate Regions: Regulatory Variant Mapping and Phenome-Wide Mendelian Randomization. International Journal of Molecular Sciences. 2026;27(22):10258. doi:10.3390/ijms272210258
BibTeX
@article{Wang2026,
author = {Wang, Li and Zhang, Le and Zhang, Song},
title = {Prioritizing Sarcopenia-Related Genes from Cross-Trait Candidate Regions: Regulatory Variant Mapping and Phenome-Wide Mendelian Randomization},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {22},
pages = {10258},
doi = {10.3390/ijms272210258}
}
EUVIMED